TITLE

C-reactive protein in patients with COPD, control smokers and non-smokers

AUTHOR(S)
Pinto-Plata, V. M.; Müllerova, H.; Toso, J. F.; Feudjo-Tepie, M.; Soriano, J. B.; Vessey, R. S.; Celli, B. R.
PUB. DATE
January 2006
SOURCE
Thorax;Jan2006, Vol. 61 Issue 1, p23
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Patients with chronic obstructive pulmonary disease (COPD) have raised serum levels of C reactive protein (CRP). This may be related directly to COPD and its associated systemic inflammation or secondary to other factors such as concomitant ischaemic heart disease (IHD) or smoking status. The aim of this study was to evaluate IHD and smoking as potential causes of raised CRP levels in COPD and to test the association between inhaled corticosteroid (ICS) use and serum CRP levels. Methods: Cross sectional analyses comparing cohorts of 88 patients with COPD, 33 smokers (S), and 38 non-smoker (NS) controls were performed. Clinical assessments included a complete medical history, pulmonary function, 6 minute walk test (6MWT), cardiopulmonary exercise test, and high sensitivity serum CRP measurements. Results: Serum CRP levels were significantly higher in patients with COPD (5.03 (1.51) mg/l) than in controls (adjusted odds ratio 9.51; 95% confidence interval 2.97 to 30.45) but were similar in the two control groups (5: 2.02 (1.04) mg/l; NS: 2.24 (1.04) mg/l). There was no clinical or exercise evidence of unstable IHD in any of the subjects. CRP levels were lower in COPD patients treated with ICS than in those not treated (3.7 (3.0) mg/l v 6.3 (3.6) mg/l); this association was confirmed in an adjusted regression model (p<0.05). Conclusion: CRP levels are raised in COPD patients without clinically relevant IHD and independent of cigarette smoking, and reduced in patients with COPD using ICS. CRP may be a systemic marker of the inflammatory process that occurs in patients with COPD.
ACCESSION #
20089477

 

Related Articles

  • Circulating alpha1-antitrypsin in the general population: Determinants and association with lung function. Senn, Oliver; Russi, Erich W.; Schindler, Christian; Imboden, Medea; von Eckardstein, Arnold; Brändli, Otto; Zemp, Elisabeth; Ackermann-Liebrich, Ursula; Berger, Wolfgang; Rochat, Thierry; Luisetti, Maurizio; Probst-Hensch, Nicole M. // Respiratory Research;2008, Vol. 9, Special section p1 

    Background: Severe alpha1-antitrypsin (AAT) deficiency associated with low AAT blood concentrations is an established genetic COPD risk factor. Less is known about the respiratory health impact of variation in AAT serum concentrations in the general population. We crosssectionally investigated...

  • Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Attaran, Davood; Lari, Shahrzad M.; Khajehdaluee, Mohammad; Ayatollahi, Hossein; Towhidi, Mohammad; Asnaashari, Amir; Marallu, Hassan Ghobadi; Mazloomi, Maryam; Mood, Mahdi Balali // Human & Experimental Toxicology;Dec2009, Vol. 28 Issue 12, p739 

    Background: Sulfur mustard (SM) is a chemical warfare agent that can cause serious pulmonary complications. This study was designed to determine serum highly sensitive C-reactive protein (hs-CRP) and evaluate its correlation with lung function parameters in patients with chronic obstructive...

  • Serum C-reactive Protein Level and Distribution in Chronic Obstructive Pulmonary Disease Versus Healthy Controls: a Case-Control Study from Iran. Firouzjahi, Alireza; Monadi, Mahmoud; Karimpoor, Fatemeh; Heidari, Behzad; Dankoob, Yahya; Hajian-Tilaki, Karim; Firozjaii, Mokarraram // Inflammation;Oct2013, Vol. 36 Issue 5, p1122 

    Inflammation has a contributive role in the development and progression of chronic obstructive pulmonary disease (COPD).The present study was designed to determine the level and the distribution of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in COPD compared with controls....

  • Value of C - Reactive Protein Measurements in Exacerbations of Chronic Obstructive Pulmonary Disease. Hussein, Methaq A. M.; Al-Kadhimi, Hashim M. // Iraqi Journal of Medical Sciences;2011, Vol. 9 Issue 1, p80 

    Background The acute phase protein, CRP, when elevated, provides good evidence of an active tissue-damaging process. Thus; its measurement provides a simple screening test for active organic disease .Increased CRP production is a very early and sensitive response to most forms of bacterial...

  • A history of second hand smoke exposure: are we asking the right questions? Crane-Godreau, Mardi A.; Payne, Peter // Frontiers in Physiology;Feb2013, p1 

    The author discusses the aspects of second hand smoke (SHS) and whether healthcare providers recognized the effects of SHS exposure on health. He also mentions a report in 2006 that highlights health implications of exposure to SHS as well as evidence that SHS contributes to coronary and lung...

  • Utility of the CAT in the therapy assessment of COPD exacerbations in China. You-Hui Tu; Yan Zhang; Guang-He Fei // BMC Pulmonary Medicine;2014, Vol. 14 Issue 1, p1 

    Background: Chronic obstructive pulmonary disease (COPD) exacerbations are accompanied with increased systemic inflammation, which accelerate the pulmonary function injury and impair the quality of life. Prompt and effective treatments for COPD exacerbations slow down the disease progression,...

  • Surveys Say: LGBT Dollars And Health Going Up in Smoke. PROXMIRE, CRYSTAL A. // Between the Lines (10807551);3/13/2014, Issue 2211, p26 

    The article reports on the 7.9-million dollar spent by lesbian, gay, bisexual and transgender communities on smoking and the rising smoking-related risks including lung cancer, chronic obstructive pulmonary disease (COPD) and coronary heart disease. It cites "The Health Consequences of...

  • Interleukin-6 and statin therapy: potential role in the management of COPD. Young, Robert P.; Hopkins, Raewyn J. // Respiratory Research;Jul2013, Vol. 14 Issue 7, p1 

    A letter to the editor is presented in response to the article "Three-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease," by R. Ferrari and colleagues in the 2013 issue.

  • Association between Serum C- reactive Protein Levels and Other Important Predictive Markers of Outcome in COPD. Shameem, Mohammad; Bhargava, Rakesh; Ahmad, Zuber; Saad, Talha; Fatima, Nazish; Malik, Abida // Acta Medica Iranica;2011, Vol. 49 Issue 1, p19 

    C-reactive protein (CRP) is an acute-phase protein synthesized predominantly by the hepatocytes in response to tissue damage or inflammation. Levels of acute-phase proteins rise rapidly, during infection and after injury. We take up the study to correlate serum CRP levels with other important...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics